Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, ChinaOACSCDCSTPCD
Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, China
Jian-Jun Sun;Ren-Fang Zhang;Li Liu;Jiang-Rong Wang;Yin-Zhong Shen;Tang-Kai Qi;Zhen-Yan Wang;Yang Tang;Wei Song;Jun Chen
Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
Diffuse large B-cell lymphomaHIV infectionOverall survivalProgression free survival
Diffuse large B-cell lymphomaHIV infectionOverall survivalProgression free survival
《中华医学杂志(英文版)》 2020 (23)
2796-2802,7
This study was supported by a grant from the National Major Scientific and Technological Special Project (No.2017ZX09304027).
评论